Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Positron Emission Tomography (PET) Scanners Market Outlook (2023 to 2033)

The positron emission tomography (PET) scanners market is estimated to be valued at US$ 1.3 billion in 2023 and is rising to US$ 2.1 billion by 2033. The market is likely to grow at a CAGR of 5.3% during the forecast period. Various factors driving the market for positron emission tomography (PET) scanners are:

  • The growing prevalence of diseases, including cancer, Alzheimer's, and others, is increasing the adoption of positron emission tomography (PET) scanners.
  • The hospital's demand for positron emission tomography (PET) scanners is rising to detect malignant and non-malignant tumors.
  • The adoption of positron emission tomography (PET) scanners detects several cancers, including breast, neck, lung, thyroid, ovarian, and cervical cancer.
  • The growing popularity of hybrid imaging systems is anticipated to boost market expansion.
  • The increasing innovative technology, stringent government regulations, and new market entrance drive the positron emission tomography (PET) scanners market growth.
  • The innovation of silicon photomultiplier (SiPM) technology and TSPO PET tracers are increasing the market growth during the forecast period.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Short Life PET Scanners Limit the Market Growth

Although the efficacy of PET scanners has been established, continuous reimbursement cutbacks are affecting the market's growth. Players have been declined reimbursement for these products worldwide, which has resulted in a reduced number for outpatient volume, thus affecting access to high-quality and cost-effective diagnostic imaging services.

Apart from this, radiopharmaceuticals used during PET scanning procedures have a short life. The systems utilize radioisotope tracers to gain better imaging capabilities, thus providing more specific information about organ function or dysfunction.

The most common radiotracer is fluorodeoxyglucose (FDG), which incorporates fluorine-18 as a tracer. It is the most used radiotracer in PET scanning and imaging. However, the radiotracer has a half-life of just under 2 hours, limiting its utility.

What are the Key Opportunities for Positron Emission Tomography Scanners Manufacturers?

The growing adoption of PET and X-ray transmission computed tomography (CT) scans is expected to boost the market in the forthcoming years. This innovative technology reduces acquisition time and provides precise attenuation correction and fusion imaging, resulting in high diagnostic sensitivity and specificity.

Moreover, the combination of PET and CT helps in the better staging of disease by defining prognostic and treatment monitoring capabilities of the functional and metabolic information given by conventional nuclear imaging techniques. Most PET scanning procedures use fluorodeoxyglucose (FDG) as it can capture tissue glucose metabolism and increase its parameters. However, fluorodeoxyglucose has a few shortcomings, such as low specificity.

Additionally, several potential radiotracers are under investigation to address the unmet clinical needs of diagnosis of diseases. In response, manufacturers are launching new products with higher sensitivity regarding metabolic activity to achieve detailed scans. Players are also investing in mergers and acquisitions to improve their product portfolios.

Attributes Details
Market CAGR (2023 to 2033) 5.3%
Market Valuation (2023) US$ 1.3 billion
Market Valuation (2033) US$ 2.1 billion
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Historical Sales Compared to 2023 to 2033 Future Outlook

Future Market Insights projects the global emission tomography (PET) scanners market to expand at a healthy 5.3% CAGR during the forecast period. Historically, the market registered a CAGR of 4.6% between 2017 and 2022.

Short Term (2022 to 2025): Increasing demand for radiopharmaceuticals, integrating computed tomography with PET, and advancements in hybrid imaging systems boost the market expansion.

Medium Term (2025 to 2028): PET scanners employ a type of nuclear medicine process to measure the metabolic activity of the body tissues and cells. They are mostly used in patients with heart or brain conditions and cancer. The process involves visualization of biochemical changes in the body, such as the metabolism of the heart muscle.

Long Term (2028 to 2033): PET scanners are widely adopted due to their ability to visualize and quantify tumoral features on molecular levels, compared to traditional techniques. Rising awareness regarding the advantages of radiotherapy and radiation oncology and a growing disposition towards non-invasive procedures are driving market opportunities.

The market is estimated to reach US$ 2.1 billion during the forecast period. In the historical period, the market stood at a valuation of US$ 1.2 billion from 2017 to 2022.

Comparative Analysis of Adjacent Markets

Positron Emission Tomography (PET) Scanners Market:

Attributes Positron Emission Tomography (PET) Scanners Market
CAGR (2023 to 2033) 5.3%
Value (2023) US$ 1.6 billion
Value (2033) US$ 3.4 billion
Trends The adoption of positron emission tomography (PET) scanners detects several cancers, including breast, neck, lung, thyroid, ovarian, and cervical cancer.
Opportunities The increasing innovative technology, stringent government regulations, and new market entrance drive the positron emission tomography (PET) scanners market.

3D Scanner Market:

Attributes 3D Scanner Market
CAGR (2023 to 2033) 7.5%
Value (2023) US$ 1.05 billion
Value (2033) US$ 2.16 billion
Trends The rising demand for 3D scanners in automobile, construction, and medical sectors drives market share.
Opportunities Innovation of 3D laser scanners and the rapidly growing mining industry propel market opportunities.

CT Scanner Market:

Attributes CT Scanner Market
CAGR (2023 to 2033) 4.7%
Value (2023) US$ 6.49 billion
Value (2033) US$ 10.27 billion
Trends The growing prevalence of diseases, technical advancement, and aging population drive market share.
Opportunities The rising adoption of computed tomography and preferences towards image-guided intervention increase market opportunities.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Top Two Segment in the Market

Segments Product Type
Top Category Full-ring PET Scanner
Historic CAGR 4.7%
Forecast CAGR 5.2%
Segments Application
Top Category Oncology
Historic CAGR 4.1%
Forecast CAGR 4.9%

Which PET Scanner Type is Most Preferred?

Based on product type, demand for full-ring PET scanners is projected to surge at a CAGR of 5.2% during the forecast period. The product offers high efficiency and contains multiple rings of scintillator detectors. These detectors cover a full 360-degree angular rotation around the volume to be imaged. Historically, the full-ring PET scanner secured a CAGR of 4.7% between 2017 and 2022.

Which is the Leading Application of PET Scanners?

In terms of applications, the oncology segment dominates the global market by securing a CAGR of 4.9% during the forecast period. The adoption of PET scanners in oncology for imaging techniques is growing the market share.

The rising demand for PET scanner in clinical trials to determine therapeutic response for novel cancer are increasing the market expansion. Historically, the oncology segment captured a CAGR of 4.1% between 2017 to 2022.

Based on the detector type, sales of lutetium oxyorthosilicate (LSO) led to more than 37.3% of the total market share in 2020. The lutetium oxyorthosilicate (LSO) segment is expected to grow at a 7.0% CAGR over the assessment period.

Based on end users, hospitals and diagnostic centers held more than 60% of the total market share in 2020. Sales in these segments are expected to grow on the back of an increasing number of diagnostic centers installed with PET imaging machines.

Top Countries Data Table Mentioned Below

Country The USA
CAGR (2017 to 2022) 4.9%
CAGR (2023 to 2023) 5.4%
Valuation (2023 to 2033) US$ 876.0 million
County The United Kingdom
CAGR (2017 to 2022) 3.5%
CAGR (2023 to 2023) 4.0%
Valuation (2023 to 2033) US$ 41.0 million
Country Germany
CAGR (2017 to 2022) 3.4%
CAGR (2023 to 2023) 4.1%
Valuation (2023 to 2033) US$ 54.7 million
Country China
CAGR (2017 to 2022) 6%
CAGR (2023 to 2023) 6.6%
Valuation (2023 to 2033) US$ 98.9 million
Country India
CAGR (2017 to 2022) 5.4%
CAGR (2023 to 2023) 4.8%
Valuation (2023 to 2033) US$ 70.7 million

What Makes the USA PET Scanners Market Attractive?

The USA is expected to dominate the North American market, securing a CAGR of 5.4% with a valuation of US$ 876.0 million during the forecast period. The rising prevalence of cancer in the country underpins the need for advanced PET scanners, thereby creating sales prospects in the market.

According to the National Cancer Institute, in 2020, an estimated 1,806,590 new cancer cases were expected to be diagnosed in the United States, and 606,520 people were expected to die from the disease. The rate of new cases of cancer (cancer incidence) is 442.4 per 100,000 men and women per year (based on 2013 to 2017 cases), as per the National Cancer Institute. Therefore, this is expected to boost The USA positron emission tomography (PET) scanners market during the forecast period. Historically, the USA market secured a CAGR of 4.9% between 2017 and 2022.

What Makes China an Emerging Market for PET Scanners?

China is capturing a CAGR of 6.6% with a valuation of US$ 98.9 million during the forecast period. Increasing efforts by manufacturers to incorporate value-based detectors in their PET machines are expected to drive sales in China.

The increasing adoption of LFS scintillation crystals for a new line of PET scanners is expected to boost the Chinese positron emission tomography (PET) scanners market. Historically, the China market secured a CAGR of 6% between 2017 and 2022.

What is the Demand Outlook for the India PET Scanners Market?

India is capturing a CAGR of 4.8% with a valuation of US$ 70.7 million during the forecast period. The country's widespread technology diffusion drives the demand for positron emission tomography (PET) scanners. Also, the increasing number of PET scanning facilities in India is expected to continue boosting their installation over the assessment period.

The present key players, advanced technology in the healthcare sector, and growing investment are driving the Indian positron emission tomography (PET) scanners market. Historically, the Indian market secured a CAGR of 5.4% between 2017 and 2022.

Competitive Landscape

Key players focus on novel and innovative approaches to develop positron emission tomography scanners. Production facility expansions, new product launches, and product approvals can strengthen their market presence

Some of the prominent players in the market are:

Recent Developments in the Positron Emission Tomography (PET) Scanners Market

  • In March 2021, the USA FDA gave clearance to Siemens Healthineers' Biograph Vision Quadra, a new PET/CT scanner with a large 106 cm axial field of view.
  • In July 2021, G.E. healthcare collaboration with Quibim, Oncovision, and Full Body Insight to innovate PET/CT total-body scanners for whole-body imaging.
  • In May 2021, G.E. Healthcare acquired Zionexa to scale Zionexa's FDA-approved PET imaging agent, Cerianna (fluoroestradiol F-18). The product is used as an adjunct to biopsy to detect estrogen receptor (E.R.) positive lesions. It helps to assist healthcare providers in treatment selection for patients with recurrent or metastatic breast cancer.

Scope of Report

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2017 to 2022
Market Analysis US$ billion for Value
Key Countries Covered The USA, Canada, Germany, The United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, and South Africa
Key Segments Covered
  • Product Type
  • Application
  • Detector Type
  • End User
  • Region
Key Companies Profiled
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing Available upon Request

Positron Emission Tomography (PET) Scanners Market by Category

By Product Type:

  • Full-ring PET Scanner
  • Partial-ring PET Scanner

By Application:

  • Oncology
  • Cardiology
  • Neurology
  • Others

By Detector Type:

  • Bismuth Germanium Oxide
  • Lutetium Oxyorthosilicate
  • Gadolinium Oxyorthosilicate
  • Lutetium Fine Silicate
  • Lutetium Yttrium Orthosilicate

By End User:

  • Hospitals
  • Diagnostic Centers
  • PET Centers
  • Research Institute

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa (MEA)

Frequently Asked Questions

What is the Current Positron Emission Tomography (PET) Scanners Market Size?

As of 2023, the PET scanners market holds a valuation of about US$ 1.3 billion.

What are the Growth Prospects for the Positron Emission Tomography (PET) Scanners Market in the Next Decade?

The PET scanners market is projected to attain a value of US$ 2.1 billion by 2033, driven by a CAGR of 5.3% between 2023 and 2033.

What are the Emerging Niches in the Positron Emission Tomography (PET) Scanners Market?

Innovative niches within the PET scanners market include hybrid imaging systems, compact mobile units, and AI-powered image analysis advancements.

What Country Controls the Positron Emission Tomography (PET) Scanners Market?

With a projected market revenue of US$ 876.0 million by 2033, the United States exerts primary control over the PET scanners market.

What are the Prevailing Trends Shaping the Positron Emission Tomography (PET) Scanners Market Landscape?

Integrated AI diagnostics and improved radioisotope availability are driving trends shaping the PET scanners market landscape.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ million) Analysis, 2017 to 2022

    4.2. Current and Future Market Size Value (US$ million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ million) Analysis By Product Type, 2017 to 2022

    5.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Product Type, 2023 to 2033

        5.3.1. Full-ring PET Scanner

        5.3.2. Partial-ring PET Scanner

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2022

    5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033

6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ million) Analysis By Application, 2017 to 2022

    6.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Application, 2023 to 2033

        6.3.1. Oncology

        6.3.2. Cardiology

        6.3.3. Neurology

        6.3.4. Others

    6.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2022

    6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033

7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Detector Type 

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ million) Analysis By Detector Type, 2017 to 2022

    7.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Detector Type, 2023 to 2033

        7.3.1. Bismuth Germanium Oxide

        7.3.2. Lutetium Oxyorthosilicate

        7.3.3. Gadolinium Oxyorthosilicate

        7.3.4. Lutetium Fine Silicate

        7.3.5. Lutetium Yttrium Orthosilicate

    7.4. Y-o-Y Growth Trend Analysis By Detector Type, 2017 to 2022

    7.5. Absolute $ Opportunity Analysis By Detector Type, 2023 to 2033

8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ million) Analysis By End User, 2017 to 2022

    8.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By End User, 2023 to 2033

        8.3.1. Hospitals

        8.3.2. Diagnostic Centers

        8.3.3. PET Centers

        8.3.4. Research Institute

    8.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022

    8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ million) Analysis By Region, 2017 to 2022

    9.3. Current Market Size Value (US$ million) Analysis and Forecast By Region, 2023 to 2033

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Western Europe

        9.3.4. Eastern Europe

        9.3.5. Asia Pacific excluding Japan(APEJ)

        9.3.6. Japan

        9.3.7. Middle East and Africa (MEA)

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

    10.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. The USA

            10.2.1.2. Canada

        10.2.2. By Product Type

        10.2.3. By Application

        10.2.4. By Detector Type

        10.2.5. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product Type

        10.3.3. By Application

        10.3.4. By Detector Type

        10.3.5. By End User

    10.4. Key Takeaways

11. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

    11.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Brazil

            11.2.1.2. Mexico

            11.2.1.3. Rest of Latin America

        11.2.2. By Product Type

        11.2.3. By Application

        11.2.4. By Detector Type

        11.2.5. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product Type

        11.3.3. By Application

        11.3.4. By Detector Type

        11.3.5. By End User

    11.4. Key Takeaways

12. Western Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

    12.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. The United Kingdom

            12.2.1.3. France

            12.2.1.4. Spain

            12.2.1.5. Italy

            12.2.1.6. Nordic countries

            12.2.1.7. BENELUX

            12.2.1.8. Rest Of Western Europe

        12.2.2. By Product Type

        12.2.3. By Application

        12.2.4. By Detector Type

        12.2.5. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product Type

        12.3.3. By Application

        12.3.4. By Detector Type

        12.3.5. By End User

    12.4. Key Takeaways

13. Eastern Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

    13.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. Russia

            13.2.1.2. Poland

            13.2.1.3. Rest Of Eastern Europe

        13.2.2. By Product Type

        13.2.3. By Application

        13.2.4. By Detector Type

        13.2.5. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product Type

        13.3.3. By Application

        13.3.4. By Detector Type

        13.3.5. By End User

    13.4. Key Takeaways

14. APEJ Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

    14.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. India

            14.2.1.3. ASEAN

            14.2.1.4. Australia & New Zealand

        14.2.2. By Product Type

        14.2.3. By Application

        14.2.4. By Detector Type

        14.2.5. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product Type

        14.3.3. By Application

        14.3.4. By Detector Type

        14.3.5. By End User

    14.4. Key Takeaways

15. Japan Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

    15.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

        15.2.2. By Product Type

        15.2.3. By Application

        15.2.4. By Detector Type

        15.2.5. By End User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product Type

        15.3.3. By Application

        15.3.4. By Detector Type

        15.3.5. By End User

    15.4. Key Takeaways

16. MEA Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    16.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

    16.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        16.2.1. By Country

            16.2.1.1. GCC countries

            16.2.1.2. South Africa

            16.2.1.3. Israel

            16.2.1.4. Rest Of MEA

        16.2.2. By Product Type

        16.2.3. By Application

        16.2.4. By Detector Type

        16.2.5. By End User

    16.3. Market Attractiveness Analysis

        16.3.1. By Country

        16.3.2. By Product Type

        16.3.3. By Application

        16.3.4. By Detector Type

        16.3.5. By End User

    16.4. Key Takeaways

17. Key Countries Market Analysis

    17.1. The USA

        17.1.1. Pricing Analysis

        17.1.2. Market Share Analysis, 2022

            17.1.2.1. By Product Type

            17.1.2.2. By Application

            17.1.2.3. By Detector Type

            17.1.2.4. By End User

    17.2. Canada

        17.2.1. Pricing Analysis

        17.2.2. Market Share Analysis, 2022

            17.2.2.1. By Product Type

            17.2.2.2. By Application

            17.2.2.3. By Detector Type

            17.2.2.4. By End User

    17.3. Brazil

        17.3.1. Pricing Analysis

        17.3.2. Market Share Analysis, 2022

            17.3.2.1. By Product Type

            17.3.2.2. By Application

            17.3.2.3. By Detector Type

            17.3.2.4. By End User

    17.4. Mexico

        17.4.1. Pricing Analysis

        17.4.2. Market Share Analysis, 2022

            17.4.2.1. By Product Type

            17.4.2.2. By Application

            17.4.2.3. By Detector Type

            17.4.2.4. By End User

    17.5. Germany

        17.5.1. Pricing Analysis

        17.5.2. Market Share Analysis, 2022

            17.5.2.1. By Product Type

            17.5.2.2. By Application

            17.5.2.3. By Detector Type

            17.5.2.4. By End User

    17.6. The United Kingdom

        17.6.1. Pricing Analysis

        17.6.2. Market Share Analysis, 2022

            17.6.2.1. By Product Type

            17.6.2.2. By Application

            17.6.2.3. By Detector Type

            17.6.2.4. By End User

    17.7. France

        17.7.1. Pricing Analysis

        17.7.2. Market Share Analysis, 2022

            17.7.2.1. By Product Type

            17.7.2.2. By Application

            17.7.2.3. By Detector Type

            17.7.2.4. By End User

    17.8. Spain

        17.8.1. Pricing Analysis

        17.8.2. Market Share Analysis, 2022

            17.8.2.1. By Product Type

            17.8.2.2. By Application

            17.8.2.3. By Detector Type

            17.8.2.4. By End User

    17.9. Italy

        17.9.1. Pricing Analysis

        17.9.2. Market Share Analysis, 2022

            17.9.2.1. By Product Type

            17.9.2.2. By Application

            17.9.2.3. By Detector Type

            17.9.2.4. By End User

    17.10. Nordic countries

        17.10.1. Pricing Analysis

        17.10.2. Market Share Analysis, 2022

            17.10.2.1. By Product Type

            17.10.2.2. By Application

            17.10.2.3. By Detector Type

            17.10.2.4. By End User

    17.11. BENELUX

        17.11.1. Pricing Analysis

        17.11.2. Market Share Analysis, 2022

            17.11.2.1. By Product Type

            17.11.2.2. By Application

            17.11.2.3. By Detector Type

            17.11.2.4. By End User

    17.12. Russia

        17.12.1. Pricing Analysis

        17.12.2. Market Share Analysis, 2022

            17.12.2.1. By Product Type

            17.12.2.2. By Application

            17.12.2.3. By Detector Type

            17.12.2.4. By End User

    17.13. Poland

        17.13.1. Pricing Analysis

        17.13.2. Market Share Analysis, 2022

            17.13.2.1. By Product Type

            17.13.2.2. By Application

            17.13.2.3. By Detector Type

            17.13.2.4. By End User

    17.14. China

        17.14.1. Pricing Analysis

        17.14.2. Market Share Analysis, 2022

            17.14.2.1. By Product Type

            17.14.2.2. By Application

            17.14.2.3. By Detector Type

            17.14.2.4. By End User

    17.15. India

        17.15.1. Pricing Analysis

        17.15.2. Market Share Analysis, 2022

            17.15.2.1. By Product Type

            17.15.2.2. By Application

            17.15.2.3. By Detector Type

            17.15.2.4. By End User

    17.16. ASEAN

        17.16.1. Pricing Analysis

        17.16.2. Market Share Analysis, 2022

            17.16.2.1. By Product Type

            17.16.2.2. By Application

            17.16.2.3. By Detector Type

            17.16.2.4. By End User

    17.17. Australia & New Zealand

        17.17.1. Pricing Analysis

        17.17.2. Market Share Analysis, 2022

            17.17.2.1. By Product Type

            17.17.2.2. By Application

            17.17.2.3. By Detector Type

            17.17.2.4. By End User

    17.18. Japan

        17.18.1. Pricing Analysis

        17.18.2. Market Share Analysis, 2022

            17.18.2.1. By Product Type

            17.18.2.2. By Application

            17.18.2.3. By Detector Type

            17.18.2.4. By End User

    17.19. GCC countries

        17.19.1. Pricing Analysis

        17.19.2. Market Share Analysis, 2022

            17.19.2.1. By Product Type

            17.19.2.2. By Application

            17.19.2.3. By Detector Type

            17.19.2.4. By End User

    17.20. South Africa

        17.20.1. Pricing Analysis

        17.20.2. Market Share Analysis, 2022

            17.20.2.1. By Product Type

            17.20.2.2. By Application

            17.20.2.3. By Detector Type

            17.20.2.4. By End User

    17.21. Israel

        17.21.1. Pricing Analysis

        17.21.2. Market Share Analysis, 2022

            17.21.2.1. By Product Type

            17.21.2.2. By Application

            17.21.2.3. By Detector Type

            17.21.2.4. By End User

18. Market Structure Analysis

    18.1. Competition Dashboard

    18.2. Competition Benchmarking

    18.3. Market Share Analysis of Top Players

        18.3.1. By Regional

        18.3.2. By Product Type

        18.3.3. By Application

        18.3.4. By Detector Type

        18.3.5. By End User

19. Competition Analysis

    19.1. Competition Deep Dive

        19.1.1. GE Healthcare

            19.1.1.1. Overview

            19.1.1.2. Product Portfolio

            19.1.1.3. Profitability by Market Segments

            19.1.1.4. Sales Footprint

            19.1.1.5. Strategy Overview

                19.1.1.5.1. Marketing Strategy

        19.1.2. Toshiba Corporation

            19.1.2.1. Overview

            19.1.2.2. Product Portfolio

            19.1.2.3. Profitability by Market Segments

            19.1.2.4. Sales Footprint

            19.1.2.5. Strategy Overview

                19.1.2.5.1. Marketing Strategy

        19.1.3. Koninklijke Philips N.V.

            19.1.3.1. Overview

            19.1.3.2. Product Portfolio

            19.1.3.3. Profitability by Market Segments

            19.1.3.4. Sales Footprint

            19.1.3.5. Strategy Overview

                19.1.3.5.1. Marketing Strategy

        19.1.4. Siemens Healthineers

            19.1.4.1. Overview

            19.1.4.2. Product Portfolio

            19.1.4.3. Profitability by Market Segments

            19.1.4.4. Sales Footprint

            19.1.4.5. Strategy Overview

                19.1.4.5.1. Marketing Strategy

        19.1.5. Hitachi Medical Corporation

            19.1.5.1. Overview

            19.1.5.2. Product Portfolio

            19.1.5.3. Profitability by Market Segments

            19.1.5.4. Sales Footprint

            19.1.5.5. Strategy Overview

                19.1.5.5.1. Marketing Strategy

        19.1.6. Positron Corporation

            19.1.6.1. Overview

            19.1.6.2. Product Portfolio

            19.1.6.3. Profitability by Market Segments

            19.1.6.4. Sales Footprint

            19.1.6.5. Strategy Overview

                19.1.6.5.1. Marketing Strategy

        19.1.7. Mediso Ltd.

            19.1.7.1. Overview

            19.1.7.2. Product Portfolio

            19.1.7.3. Profitability by Market Segments

            19.1.7.4. Sales Footprint

            19.1.7.5. Strategy Overview

                19.1.7.5.1. Marketing Strategy

        19.1.8. Yangzhou Kindsway Biotech Co.Ltd

            19.1.8.1. Overview

            19.1.8.2. Product Portfolio

            19.1.8.3. Profitability by Market Segments

            19.1.8.4. Sales Footprint

            19.1.8.5. Strategy Overview

                19.1.8.5.1. Marketing Strategy

        19.1.9. Oncovision

            19.1.9.1. Overview

            19.1.9.2. Product Portfolio

            19.1.9.3. Profitability by Market Segments

            19.1.9.4. Sales Footprint

            19.1.9.5. Strategy Overview

                19.1.9.5.1. Marketing Strategy

        19.1.10. Canon Medical Systems Corporation

            19.1.10.1. Overview

            19.1.10.2. Product Portfolio

            19.1.10.3. Profitability by Market Segments

            19.1.10.4. Sales Footprint

            19.1.10.5. Strategy Overview

                19.1.10.5.1. Marketing Strategy

20. Assumptions & Acronyms Used

21. Research Methodology

Recommendations

Healthcare

Computed Tomography Market

Published : June 2024

Explore Healthcare Insights

View Reports

Positron Emission Tomography (PET) Scanners Market